Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI Resting-State Networks in Parkinson's Disease and Intervention Evaluation
ChiCTR-TRC-09000507Phase 4Completed
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levodopa + benserazide in Parkinson's disease (PD) (3 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Regional homogeneity (ReHo), Functional connectivity and 1 more. Started Oct 2008; status: completed.
02
Drugs
levodopa + benserazide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000507.